Search Results - "Catino, A M"

1746PPrognostic role of RLF/MYCL1 and circPVT1 in SCLC by Storlazzi, C T, Longo, V, Tommasi, S, Tolomeo, D, Traversa, D, Visci, G, Lonoce, A, Macchia, G, Labbate, A, D’addabbo, P, Pizzutilo, P, Muscarella, L, Petriella, D, Lacalamita, R, Zito, F A, Botticella, M A, Catino, A M, Galetta, D

“…Abstract Background Small Cell Lung Cancer (SCLC) is a highly metastatic form of lung cancer and the therapies remain unchanged since 40 years. Therefore, the…”
Get full text

M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinoma by Lorusso, V, Berardi, F, Brandi, M, Mastria, A, Paradiso, A, Catino, A M, Tatulli, C, De Lena, M

“…Urothelial cancer is a chemosensitive disease. However, cisplatin or anthracycline-containing regimens still provoke severe toxicity mainly due to reduced…”
Get more information

pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer by Correale, M, Abbate, I, Paradiso, A, Schittulli, F, Dragone, C D, Tedone, T, Gargano, G, Catino, A M, Musci, M D, De Lena, M

“…Using a new immunoradiometric assay (ELSA pS2 Cis-France), a total of 200 cytosols obtained from primary breast tumors were examined for pS2 content, which is…”
Get full text

Humoral and cellular immune responses to Salmonella typhi in patients with typhoid fever by Mastroianni, C M, Jirillo, E, De Simone, C, Grassi, P P, Maffione, A B, Catino, A M, Vullo, V, Misefari, A, Delia, S

“…Humoral and cellular immune responses to Salmonella typhi have been studied in nine children with typhoid fever. By using dot immunobinding assay,…”
Get more information

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer by Paradiso, A, Mangia, A, Barletta, A, Catino, A M, Giannuzzi, A, Schittulli, F, Radogna, N, Longo, S, Palmieri, D, Marzullo, F

“…A prospective randomised clinical trial in patients with node-negative, fast-proliferating breast cancer was initiated in January 1990 to verify the…”
Get full text

Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results by Izzo, F., Catino, A. M., Vogl, T. J., Middleton, M., Valle, J. W., Fiore, F., Gadaleta, C. D., Pirotta, R. M., Martignoni, M., Laffranchi, B.

“…Abstract only 4593 Background: Nemorubicin is a novel DNA-intercalator, mainly metabolized in liver by CYP3A4 enzyme and showing synergic antitumor activity…”
Get full text

Behaviour of four serum tumor markers in pregnant women by Correale, M, Abbate, I, Dragone, C D, Tedone, T, Musci, M D, Gargano, G, Catino, A M, Bafunno, A M, Grossi, B

Get more information

Breast conservation therapy as a safe and effective alternative to mastectomy for selected T4 patients treated with primary chemotherapy as part of multimodality approach by Ionta, M. T., Scanu, A., Masia, G. L., Carta, A. M., Contu, A., Farris, A., Catino, A. M., Palmeri, S., Minerba, L., Massidda, B.

“…Abstract only…”
Get full text

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer. Discussion by PARADISO, A, MANGIA, A, NATALE, C, TARDIO, B, DE LENA, M, VAN DE VELDE, C. J. H, HORTOBAGYI, G. N, MOURIDSEN, H. T, BARLETTA, A, CATINO, A. M, GIANNUZZI, A, SCHITTULLI, F, RADOGNA, N, LONGO, S, PALMIERI, D, MARZULLO, F

Get full text